These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy. Essayagh B, Resseguier N, Michel N, Casalta AC, Renard S, Donghi V, Carbone A, Piazzai C, Ambrosi P, Levy F, Martel H, Gérard H, Avierinos JF, N'Guyen K, Habib G. Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326 [Abstract] [Full Text] [Related]
8. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I. Circulation; 2018 Oct 02; 138(14):1387-1398. PubMed ID: 30297972 [Abstract] [Full Text] [Related]
11. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device. Wilke I, Witzel K, Münch J, Pecha S, Blankenberg S, Reichenspurner H, Willems S, Patten M, Aydin A. J Cardiovasc Electrophysiol; 2016 Jul 02; 27(7):779-84. PubMed ID: 27060297 [Abstract] [Full Text] [Related]
13. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization. de Sisti A, Toussaint JF, Lavergne T, Ollitrault J, Abergel E, Paziaud O, Ait Said M, Sader R, LE Heuzey JY, Guize L. Pacing Clin Electrophysiol; 2005 Dec 02; 28(12):1260-70. PubMed ID: 16403157 [Abstract] [Full Text] [Related]
14. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy. Fumagalli C, Maurizi N, Day SM, Ashley EA, Michels M, Colan SD, Jacoby D, Marchionni N, Vincent-Tompkins J, Ho CY, Olivotto I, SHARE Investigators. JAMA Cardiol; 2020 Jan 01; 5(1):65-72. PubMed ID: 31693057 [Abstract] [Full Text] [Related]
18. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS. J Am Coll Cardiol; 2015 May 12; 65(18):1915-28. PubMed ID: 25953744 [Abstract] [Full Text] [Related]
19. Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation. Hayashi H, Iwasaki YK, Arai T, Mimuro R, Hachisuka M, Maru Y, Fujimoto Y, Oka E, Hagiwara K, Imori Y, Yamamoto T, Murata H, Yodogawa K, Takano H, Shimizu W. Heart Vessels; 2021 May 12; 36(5):667-674. PubMed ID: 33221953 [Abstract] [Full Text] [Related]
20. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry. Valzania C, Gadler F, Boriani G, Rapezzi C, Eriksson MJ. Scand Cardiovasc J; 2020 Aug 12; 54(4):239-247. PubMed ID: 32054352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]